These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8998837)

  • 1. Synthesis and pharmacological evaluation of N-(6-functionalized-amino-3-pyridyl)-N'-bicycloalkyl-N''-cyanoguanidine s as antihypertensive agents.
    Eda M; Takemoto T; Okada T; Sakashita H; Matzno S; Gohda M; Hayashi K; Nakamura N; Fukaya C
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):307-13. PubMed ID: 8998837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel potassium-channel openers: preparation and pharmacological evaluation of racemic and optically active N-(6-amino-3-pyridyl)-N'-bicycloalkyl-N"-cyanoguanidine derivatives.
    Eda M; Takemoto T; Ono S; Okada T; Kosaka K; Gohda M; Matzno S; Nakamura N; Fukaya C
    J Med Chem; 1994 Jun; 37(13):1983-90. PubMed ID: 8027980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel potassium channel openers: synthesis and pharmacological evaluation of new N-(substituted-3-pyridyl)-N'-alkylthioureas and related compounds.
    Takemoto T; Eda M; Okada T; Sakashita H; Matzno S; Gohda M; Ebisu H; Nakamura N; Fukaya C; Hihara M
    J Med Chem; 1994 Jan; 37(1):18-25. PubMed ID: 8289193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of novel phenylcyanoguanidine derivatives as potassium channel openers.
    Yoshiizumi K; Ikeda S; Goto K; Morita T; Nishimura N; Sukamoto T; Yoshino K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2042-50. PubMed ID: 8945769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.
    Southerton JS; Weston AH; Bray KM; Newgreen DT; Taylor SG
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):310-8. PubMed ID: 2848206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of thienylcyanoguanidine derivatives as potassium channel openers.
    Yoshiizumi K; Ikeda S; Nishimura N; Yoshino K
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2005-10. PubMed ID: 9433770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies on the mode of action of pinacidil.
    Weston AH; Bray KM; Duty S; McHarg AD; Newgreen DT; Southerton JS
    Drugs; 1988; 36 Suppl 7():10-28. PubMed ID: 2855517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G; Henshaw M; Miller M; Weston AH
    Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers.
    Yamamoto S; Hashiguchi S; Miki S; Igata Y; Watanabe T; Shiraishi M
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):734-45. PubMed ID: 8681405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD; Clapham JC; Wilson C; Hamilton TC
    J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive rat.
    Clapham JC; Trail BK; Hamilton TC
    Eur J Pharmacol; 1994 May; 257(1-2):79-85. PubMed ID: 8082711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of K+ channel openers on the vascular actions of human gamma globulin.
    Abrahams Z; Sutter MC
    Eur J Pharmacol; 1994 Feb; 252(2):195-203. PubMed ID: 7512504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
    Zhang H; Stockbridge N; Weir B
    Adv Exp Med Biol; 1991; 304():531-41. PubMed ID: 1839488
    [No Abstract]   [Full Text] [Related]  

  • 17. Pinacidil inhibits the ryanodine-sensitive outward current and glibenclamide antagonizes its action in cells from the rabbit portal vein.
    Xiong ZL; Kajioka S; Sakai T; Kitamura K; Kuriyama H
    Br J Pharmacol; 1991 Apr; 102(4):788-90. PubMed ID: 1906767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,2-Dialkylnaphthalen-1-ones as new potassium channel activators.
    Almansa C; Gómez LA; Cavalcanti FL; Rodríguez R; Carceller E; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1993 Jul; 36(15):2121-33. PubMed ID: 8340916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiophene systems. 14. Synthesis and antihypertensive activity of novel 7-(cyclic amido)-6-hydroxythieno[3,2-b]pyrans and related compounds as new potassium channel activators.
    Sanfilippo PJ; McNally JJ; Press JB; Fitzpatrick LJ; Urbanski MJ; Katz LB; Giardino E; Falotico R; Salata J; Moore JB
    J Med Chem; 1992 Nov; 35(23):4425-33. PubMed ID: 1447742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introductory remarks: symposium on pinacidil: potassium channel openers in the treatment of hypertension.
    Weston AH
    Drugs; 1988; 36 Suppl 7():1-3. PubMed ID: 3254828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.